Skip to Content
Merck
  • Upper airway obstruction by epiglottis and arytenoids hematoma in a patient treated with warfarin sodium.

Upper airway obstruction by epiglottis and arytenoids hematoma in a patient treated with warfarin sodium.

Auris, nasus, larynx (2009-05-05)
Ryoukichi Ikeda, Toshihiko Chiba, Shigeki Gorai, Toshimitu Kobayashi
ABSTRACT

With the increase in the number of patients undergoing warfarin therapy, reports of complications due to such therapy have become frequent. Although upper airway obstruction secondary to bleeding resulting from warfarin therapy is rare, it is a life-threatening complication because of the risk of airway obstruction. Only one previous case of hematoma of the epiglottis and arytenoids has been reported. We here in report a case of an 83-year-old woman on warfarin therapy who presented with a sore throat. On flexible nasoendoscopy, edema of the epiglottis and bilateral arytenoids with a red and purple hue were observed. The left true vocal cord was erythematous, but the airway was adequately maintained. The PT-INR of the patient was 10. She was managed conservatively and had a good course.

MATERIALS
Product Number
Brand
Product Description

Supelco
Hydrocortisone 21-hemisuccinate, analytical standard
Sigma-Aldrich
Hydrocortisone 21-hemisuccinate sodium salt, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydrocortisone 21-hemisuccinate sodium salt, ≥90% (HPLC)